OTC: NVSEF - Novartis AG

Yield per half year: +5.68%
Dividend yield: +3.31%
Sector: Healthcare

Novartis AG

126.00126.00117.00117.00108.00108.0099.0099.0090.0090.0081.0081.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
16.22 31.32 -48.22% 19.76 -17.93%
P/S 3.74 3.24 15.46%
P/BV 4.39 3.11 41.08%
P/FCF 15.25 16.62 -8.24%
Ev/Ebitda 10.31 10.15 1.51%
Ev/S 4.13 1.93 114.29%
Ev/FCF 15.46 13.99 10.55%
E/P 0.0567 1.47 -96.14%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
40.05 25.02 60.06% 34.81 +15.05%
ROE 26.33 13.38 96.79%
ROA 11.81 6.22 89.82%
ROIC 27.51 15.56 76.81%
ROS 23.09 12.85 79.7%
ROCE 33.19 13.48 146.16%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.51 6.27 -75.95% 1.43 +5.57%
Nеt Debt/Ebitda 0.9558 -5.75 -116.61%
Debt/Ratio 0.3057 0.2174 40.6%
Debt/Equity 0.8469 3.24 -73.84%
Debt/Net Income 2.62 15.14 -82.71%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
8.28/10
3.31 1.53 115.99% 3.31 +0.0458%
Number of years of dividend growth 1 1.3 -22.83%
DSI 0.8571 0.7874 8.86%
Average dividend growth 4.37 -247.1 -101.77%
Average percentage for 5 years 3.31 2.81 17.89%
Average percentage for payments 55.34 245.62 -77.47%
Difference from average difference in sector 1.78

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
3.94 56.72 -93.05%
Growth impulse Ebitda in 5 years 19.95 39.91 -50.01%
Growth impulse Net Income in 5 years 47.97 46.39 3.41%
Growth impulse FCF in 5 years 24.76 26.84 -7.75%
Growth impulse EPS in 5 years 68.31 111.63 -38.81%
IP Score
6.91/10

Similar companies

WuXi Biologics (Cayman) Inc.

Roche Holding

Sinopharm Group Co., Ltd.

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription